www.fdanews.com/articles/82089-allergan-3q-profit-beats-estimates
ALLERGAN 3Q PROFIT BEATS ESTIMATES
November 1, 2005
Allergan Inc., maker of eye care products and the Botox wrinkle injection, said
Tuesday that its third-quarter profit jumped 64 percent. The results beat Wall
Street estimates. The company also raised its guidance for 2005, sending its
shares up $2.14, or 2.4 percent, to $91.44 in morning trading on the New York
Stock Exchange. The stock has traded between $69.01 and $95.43 over the past
year.
Yahoo News